Preferred Label : Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7;
NCIt synonyms : Stage II Lymphoepithelioma of the Nasopharynx; Stage II Nasopharyngeal Lymphoepithelioma; Nasopharyngeal Undifferentiated Carcinoma Stage II; Stage II Lymphoepithelioma of Nasopharynx; Stage II Nasopharyngeal Undifferentiated Carcinoma;
NCIt related terms : Stage II Undifferentiated Nasopharyngeal Throat Cancer;
NCIt definition : Stage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Nasopharyngeal cancer
with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal
cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral
infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal
extension denotes posterolateral infiltration of tumor. N0: No regional lymph node
metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph
node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or
unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension.
Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th
ed.);
Neoplastic status : Malignant;
Origin ID : C8225;
UMLS CUI : C0280381;
Currated CISMeF NLP mapping
- Disease excludes abnormal cell
- Disease may have findings
- Has associated anatomic sites
- Semantic type(s)
- UMLS correspondences (same concept)
- concept_is_in_subset
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_associated_disease
- disease_has_finding
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_is_stage
- disease_mapped_to_gene
- disease_may_have_cytogenetic_abnormality
- disease_may_have_molecular_abnormality
